Pulsed Field Ablation Procedures Found Safe and Effective for Atrial Fibrillation Patients

Mount Sinai-led study demonstrates significant safety outcomes and could lead to more frequent use of this new technology

Mount Sinai Expands Center for Post-COVID Care to Serve Patients in East Harlem and South Bronx

$5 million grant from the Agency for Healthcare Research and Quality will enhance long COVID care for underserved minority groups, community outreach, and research

Benjamin S. Abella, MD, MPhil, Named as Chair of the Department of Emergency Medicine for the Mount Sinai Health System

Benjamin S. Abella, MD, MPhil, a national leader in the study of sudden cardiac arrest and cardiopulmonary resuscitation (CPR), has been appointed Chair of the Department of Emergency Medicine for the Icahn School of Medicine at Mount Sinai and the Mount Sinai Health System.

Valentin Fuster, MD, PhD, Received 2024 Distinguished Award From European Society for Clinical Investigation (ESCI)

President of Mount Sinai Fuster Heart Hospital given top honor for his scientific excellence and successful global education initiatives on cardiovascular disease

RNA Inhibitor Is Shown Safe and Effective in Reducing a Wide Range of Cholesterol and Triglyceride Levels in the Blood in Mount Sinai-Led Clinical Trial

A small interfering RNA (siRNA) investigational therapy that inhibits a gene involved in lipoprotein metabolism has been shown in a clinical trial led by Mount Sinai researchers to significantly reduce levels of different types of cholesterol and triglycerides in individuals with mixed hyperlipidemia, a condition in which fats build up in the blood.

Two New Studies by Mount Sinai Researchers in Science Offer Key Insights Into the Origins and Potential Treatment of Mental Health Disorders

Working under the umbrella of the PsychENCODE Consortium, the mental health research project established in 2015 by the National Institutes of Health, a team of Mount Sinai scientists has uncovered important new insights into the molecular biology of neuropsychiatric disease through two new studies published in a special issue of Science on Friday, May 24.

Mount Sinai Experts to Present New Research on Long COVID, Lung Cancer, Asthma, Sleep Apnea, and More at ATS 2024 International Conference

Available for interview on breaking news, trending topics in respiratory medicine

Mount Sinai Experts to Present New Research on Preeclampsia, Preterm Birth, Doula Care and More at the 2024 ACOG Annual Clinical and Scientific Meeting

Women’s health doctors and researchers will share new insights on prenatal care

Mount Sinai’s Yvette Calderon, MD, MS, Receives Prestigious Award From Society for Academic Emergency Medicine

Top honor recognizes her commitment to justice, equity, diversity, and inclusion through scholarship, mentorship, and leadership

Mount Sinai Experts Available for Interview During Women’s Health Awareness Month

  Mount Sinai Experts Available for Interview During Women’s Health Awareness Month  As we continue to recognize May as Women’s Health Awareness Month, and kick off National Women’s Health Week on Sunday, May 12, I want to flag Mount Sinai…

Mount Sinai Scientists Unravel How Psychedelic Drugs Interact with Serotonin Receptors to Potentially Produce Therapeutic Benefits

Researchers at the Icahn School of Medicine at Mount Sinai have shed valuable light on the complex mechanisms by which a class of psychedelic drugs binds to and activates serotonin receptors to produce potential therapeutic effects in patients with neuropsychiatric disorders such as depression and anxiety.

A Common Pathway in the Brain That Enables Addictive Drugs to Hijack Natural Reward Processing Has Been Identified by Mount Sinai

Mount Sinai researchers, in collaboration with scientists at The Rockefeller University, have uncovered a mechanism in the brain that allows cocaine and morphine to take over natural reward processing systems.

Mount Sinai Study Calls for Major Changes in the Way People With Comorbidities Are Selected by Physicians for Lung Cancer Screening

A Medicare policy requiring primary care providers (PCPs) to share in the decision-making with patients on whether to proceed with lung cancer screening is fraught with confusion and lack of evidence-based information, and may actually be undermining the purpose for which it was created, Mount Sinai researchers say.

Mount Sinai Is First in New York to Study a Brain-Computer Interface Designed to Record and Map the Brain’s Activity in Unprecedented Detail

A multidisciplinary team of neurosurgeons and neuroscientists from the Icahn School of Medicine at Mount Sinai are the first in New York to study a new brain-computer interface that’s engineered to map a large area of the brain’s surface, in real time, at resolutions hundreds of times more detailed than typical arrays used in neurosurgical procedures.

Mount Sinai Experts Available for Interview During Endometriosis Awareness Month

Contact: Stacy A. Anderson                     Mount Sinai Press Office                     347-346-3390                     [email protected]                            (New York, NY – March 21, 2024) – As we continue to recognize March as Endometriosis Awareness Month, observed to bring attention to the…

Mount Sinai Doctors to Present New Research at 2024 SMFM Annual Pregnancy Meeting

High-risk pregnancy specialists from the Mount Sinai Health System are presenting research at the Annual Pregnancy Meeting of the Society for Maternal-Fetal Medicine (SMFM) from February 10-14

Mount Sinai Ophthalmologists Develop Novel Protocol to Rapidly Diagnose and Treat Eye Stroke

Study shows using advanced technology and time can prevent permanent vision loss

Mount Sinai Researchers Awarded $4.1 Million NIH Grant to Advance Understanding of Sleep Apnea Using Artificial Intelligence

Machine-learning method aims to predict consequences of serious sleep disorder impacting millions in the U.S.

Posterior Wall Ablation Does Not Help Patients With Persistent Atrial Fibrillation

FOR IMMEDIATE RELEASE                  Contact:  Ilana Nikravesh                  Mount Sinai Press Office                  212-241-9200                   [email protected]   …

Researchers Discover Why One Type of Chemotherapy Works Best in Bladder Cancer

Tisch Cancer Institute researchers discovered that a certain type of chemotherapy improves the immune system’s ability to fight off bladder cancer, particularly when combined with immunotherapy, according to a study published in Cell Reports Medicine in January.

Mount Sinai Researchers Receive $7 Million to Improve Outcomes for High-risk Blood Cancer Patients From the Multiple Myeloma Research Foundation

The Mount Sinai Health System has received a $7 million grant from the Multiple Myeloma Research Foundation for a three-year project that aims to fast-track novel translational concepts to improve outcomes for people with high risk myeloma, the second most common blood cancer in the United States.

Largest Brain Autopsy Study of Female Intimate Partner Violence Decedents Reveals Brain Injury Pathology Unlike That Seen Among Male Contact Sports Athletes

The largest brain autopsy study of women who had experienced intimate partner violence reveals substantial vascular and white matter damage in the brain, but no evidence of chronic traumatic encephalopathy (CTE), the neurodegenerative disease recognized among male contact sports athletes who sustain repeated head trauma.

Mount Sinai Receives $4.6 Million From The Pershing Square Foundation to Support Women’s Health Research and Careers for Women in Science

The Icahn School of Medicine at Mount Sinai has received a $4.6 million gift from The Pershing Square Foundation to support women’s health research and advance careers for female scientists

Mount Sinai Renames Top-Ranked Heart Hospital to Honor Valentin Fuster, MD, PhD, and His Legacy of Excellence

“Mount Sinai Fuster Heart Hospital” furthers vision of world-leading cardiac care and research that prevents heart disease worldwide

Adding Immunotherapy to Chemotherapy Regimen Improves Survival in Metastatic Bladder Cancer Patients

A clinical trial co-led by Mount Sinai researchers is the first to show that using chemotherapy with immunotherapy resulted in improved survival in patients with an advanced type of bladder cancer. The results were simultaneously reported in The New England Journal of Medicine and at the annual meeting of the European Society for Medical Oncology.

Oula Announces Third Clinic And Expanded Partnership With Mount Sinai Health System To Provide Wider Access To Collaborative Maternity Care

Oula-Mount Sinai West partnership offers patients the best of obstetrics and midwifery, with midwife-led delivery supported by leading hospital’s expertise and resources

CastleVax Inc. Receives BARDA Project NextGen Award Valued at up to $338 Million to Advance Intranasal NDV-based COVID-19 Booster Vaccine into Phase 2b Clinical Efficacy Testing

CastleVax, a clinical stage vaccine platform company, has received a Project NexGen award valued at up to $338 million from the Biomedical Advanced Research and Development Authority (BARDA), to support the development of a next-generation, booster vaccine to protect against COVID-19 for years to come.

Mount Sinai Announces Partnership With the Chiba Institute of Technology in Japan Focusing on Artificial Intelligence to Transform Cardiovascular Research

Agreement aims to help make clinical trials more efficient and lead to faster advances in patient care

Advanced Bladder Cancer Patients Could Keep Their Bladder Under New Treatment Regime, Clinical Trial Shows

Mount Sinai investigators have developed a new approach for treating invasive bladder cancer without the need for surgical removal of the bladder, according to a study published in Nature Medicine in September.

Mount Sinai Rehabilitation Centers Ranked Among the Best in the United States by Newsweek

Top rankings include Mount Sinai Morningside and The Mount Sinai Hospital, with stroke rehabilitation a standout program

People with Long COVID Have Distinct Hormonal and Immune Differences From Those Without This Condition

Research conducted at Mount Sinai and Yale confirms long COVID is a biological disease by showing blood biomarkers that can predict who has it